Generated: April 27, 2017
|Title:||Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis|
|Abstract:||Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis. ##STR00001##|
|Inventor(s):||Bohn; Manfred (Hofheim, DE), Kraemer; Karl Theodor (Langen, DE), Markus; Astrid (Liederbach, DE)|
|Assignee:||Medicis Pharmaceutical Corporation (Scottsdale, AZ)|
|Patent Claims:||1. A method of treating seborrheic dermatitis comprising administering to the affected area of the skin of a human having seborrheic dermatitis an amount effective for the treatment of seborrheic dermatitis of a composition comprising only one active ingredient, the active ingredient consisting of ciclopirox, and at least one surfactant; wherein the composition has a pH ranging from about 4.5 to about 6.5; and wherein the composition is a single composition.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.